Immunologic factors in primary progressive multiple sclerosis
- 1 May 2004
- journal article
- research article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 10 (3_suppl) , S16-S22
Abstract
Primary progressive multiple sclerosis (PPMS) is clinically character ized by progression without remission or relapse, in contrast to relapsing forms of MS. Pathologic and imaging findings also indicate that PPMS differs from relapsing forms. Recent studies examining potential immunologic differences among MS forms suggest that cytokine and adhesion molecule expression profiles, but not chemokine recepto r profiles, in PPMS patients resemble those in healthy controls more than those in patients with relapsing MS. However, the significance of these findings remains to be fully elucidated, and there is little additional evidence as yet of marked differences among MS forms based on immunologic characteristics. O f interest are the recent demonstrations that activated immune cells produce brain-derived neurotrophic factor (BDNF), a neuroprotective factor, in MS lesions, that BDNF receptors are located in MS tissue, and that glatiramer acetate (GA)-specific T cells produce BDNF irrespective of T helper cell Th1 or Th2 pheno type. These findings both support the concept of a protective inflammation in MS and suggest an additional mechanism of action for the clinical effects of G A therapy in MS. Whether and to what extent this mechanism is present in different MS forms remain to be clarified.Keywords
This publication has 13 references indexed in Scilit:
- Multiple sclerosis: Brain-infiltrating CD8+T cells persist as clonal expansions in the cerebrospinal fluid and bloodProceedings of the National Academy of Sciences, 2004
- Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating EventNew England Journal of Medicine, 2003
- Neurotrophic cross‐talk between the nervous and immune systems: Implications for neurological diseasesAnnals of Neurology, 2003
- Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapyBrain, 2002
- BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?Brain, 2002
- Anti-MOG and anti-MBP antibody subclasses in multiple sclerosisMultiple Sclerosis Journal, 2001
- Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain ReactionJournal of Experimental Medicine, 2000
- Diagnostic criteria for primary progressive multiple sclerosis: A position paperAnnals of Neurology, 2000
- Immunological profile of patients with primary progressive multiple sclerosisBrain, 1999
- Activated Human T Cells, B Cells, and Monocytes Produce Brain-derived Neurotrophic Factor In Vitro and in Inflammatory Brain Lesions: A Neuroprotective Role of Inflammation?Journal of Experimental Medicine, 1999